Bone Screw System Market is likely to grow at a CAGR of 6.4% through 2028

Future Market Insights tracks the performance of the global bone screw system market in a new publication titled “Bone Screw System Market: Global Industry Analysis 2013 – 2021 and Opportunity Assessment 2022 – 2028”. The bone screw system market is anticipated to record a year-over-year growth rate of 6.5% and reach a market value of US$ 1,963 Mn in 2028. Titanium will continue to account for the leading market revenue share by Material Type, accounting for 45.0% share of the global bone screw system market in 2022. In this report, the bone screw system market is segmented based on material type, patient anatomy, end user and region.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-4050

Bone Screw System Market: Segmental Insights

Lower extremity segment leads the market for bone screw system owing to increasing number of cases registered due to prolonged effects of osteoporosis among the mass population. In contrast, there are limited number of companies conducting research activities for introducing novel products in the market. In terms of revenues, the lower extremity segment is expected to account for the largest revenue share of 39.2% in 2022 and is expected to witness significant growth during the forecast period. This growth in the lower extremity segment is expected to be primarily driven by rising awareness among the geriatric population and increasing number of orthopaedic cases undergoing surgical interventions.

Stainless steel is likely to be the preferred choice of material used in common practice due to its ready availability and cost efficiency as compared to titanium based screws and bioabsorbable material. Titanium holds a major share in the global market currently due to widespread usage. The bioabsorbable material segment has limited adoption in the market due to premium pricing over other bone screw products.

Among end users, hospitals are expected to hold the maximum share in the overall bone screw system market due to the large number of surgical procedures performed in hospitals using bone screws as compared to other end users such as ambulatory surgical centres and clinics. The hospitals end user segment is estimated to hold a market share of 65.6% in 2022.

Bone Screw System Market: Trends

Computer assisted technology is a revolutionary concept used in orthopaedic treatment procedures. Companies are focussing on collaboration with all end users to develop new effective products with better user interfaces. They are involving breakthrough options in this market to initiate a sense of revolution in using more advanced alternatives. In 2016, Surgebright in cooperation with the German Institute for Tissue and Cell Replacement (DIZG) in Berlin developed latest technology that uses real bone material to form a screw. 3D printing is another innovative technology that could be used in developing bone screws in the near future.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4050

Bone Screw System Market: Regional Insights

The report tracks the global bone screw system market across the key geographies of North America, Europe, Latin America, Asia Pacific Excluding China, China and Middle East & Africa. This report assesses the trends driving each regional market and offers analysis and insights about the bone screw system market across specific countries in the assessed regions. North America accounts for a major share in the global bone screw system market and is expected to grow at a CAGR of 7.1% during the period of assessment. North America is projected to be the most lucrative market in the global bone screw system market with an attractiveness index of 2.3 during the forecast period due to the presence of leading manufacturers and implementation of healthcare reforms in the region.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-4050

Bone Screw System Market: Competition Tracking

The key players operating in the bone screw system market include companies such as Stryker Corporation, Zimmer Biomet Holdings Inc, CONMED Corporation, Arthrex, Orthofix, SMITH & NEPHEW, Johnson & Johnson (DePuy Synthes), Integra LifeSciences, Wright Medical Group N.V, SURGIVAL INTERNATIONAL, Spineology Inc, GPC Medical ltd., Osteogenics Biomedical,  Altimed, JEIL MEDICAL CORPORATION, Fine Science Tools, MEIRA Inc. and Medtronic.

To study the growth strategies of the top manufacturers of bone screw systems and to understand the current market structure, write to Future Market Insights analysts at press@futuremarketinsights.com

Blood Bank Reagent Market Size by 2027: Global Demand and Regional Analysis

Growing need of blood on the daily basis in hospitals, ambulatory surgical centers and several multispecialty centers increases the demand for blood bank reagents in blood banks in order to maintain the keep up the supply of blood. Reagents are crucial testing reagents used by several hospitals and blood banks to determine and identify the antibody type in the donors and patient’s blood, thus ensuring the blood transfusion to be safe and effective. During every blood transfusion, patients’ blood is tested with the donor’s reagents in order to identify the harmful antibodies thus, decreasing the risk of any potential infection. Antibodies are blood proteins produced by the plasma cells to protect the body against several infections.

Routinely performed blood banking procedures includes several reagents used for blood groping, antibody screening and cross matching/compatibility testing. Blood groping reagents are intended for determining the ABO blood group and Rh type from the donor’s blood. Blood groping reagents are made from the antibodies derived from the in-vitro cultures of hybridomas of murine and human origin and include, antigens against blood group A, B, A & B, D, Anti-C, Anti-c, Anti-E, Anti-e, and Anti-K for ABO typing. Anti-D is the most important Rh reagent for Rh typing. Antibody screening reagents are used for identification of antibodies with specificity of red blood cells (RBC) antigens.

Antibody screening reagents are used to test donor plasma cells in order to make sure than no unexpected antibodies are transfused in to the patient’s body thus allowing detection of unexpected antibodies particularly alloantibodies in the RBC’s. Antibodies including, Duffy, Kell, Kidd, MNS, P, and certain Rh types that are considered clinically significant. Cross matching reagents are used to ensure whether the blood can be transfused in the recipient’s body prior to the blood transfusion procedure.

The market for blood bank reagents is expected to witness healthy growth over the forecast period. The antibody screening testing is essential as it prevents hemolytic transfusion reactions from occurring.

Get a Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2881

Blood Bank Reagent Market: Drivers & Restraints

Blood bank reagents market is expected to witness higher demand over the forecast period owing to increasing prevalence of various diseases and expanded need of blood during several surgical procedures. Furthermore, increasing government initiatives regarding the necessity of donation of blood and other tissues and organs through education, safety of blood transfusion and several blood donation campaigns are pushing more number of blood donors in blood bank. This is expected to positively affect the market growth of blood bank regents market over the forecast period. Screening of donor’s blood during the blood transfusion is mandatory in order to avoid severe transfusion reaction if large amount of whole blood is transfused into the recipient’s body.  However, lack of awareness and lack of skilled and trained professionals can lead to misleading transfusion thus, leading to declining sales of blood bank reagents market globally.

Blood Bank Reagent Market: Overview

Blood group typing reagents are essential tools for diagnostic laboratories specialized in blood group serology. Increasing number of blood transfusion procedures globally is expected to create higher demand for blood bank reagents in the coming years. This is attributed to large demand of blood from the hospitals, ambulatory surgical centers and several other healthcare facilities. Blood bank reagents are important to ensure whether donor’s blood can be transfused to the recipient. In addition, expanded use of blood bank reagents for research purpose is further expected to fuel the market of blood bank reagents over the forecast period.

Request Brochure of Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2881

Blood Bank Reagent Market: Region-wise Outlook

On the basis of region presence, Blood Bank Reagent market is segmented into seven key regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific excluding japan, Japan, Middle East and Africa. Continuous rise in the demand for blood and high rates of blood donation procedures are expected to fuel the market growth of blood bank regents market in North America. Also, large number of blood banks in the region as compared to other regions is further expected to result in escalating revenues in the region. Several promotional blood donation campaigns and large volume of blood donors and set up of guidelines for reagent manufacturers in several North American, European countries is expected to fuel the market growth of blood bank reagents in the near future.

Blood Bank Reagent Market: Key Players

Some of the key market players in the Blood Bank Reagent market are, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Cardinal Health, Ortho Clinical Diagnostics, Quotient, Ltd. Lorne Laboratories Limited, Immucor, Inc., Thermo Fisher Scientific Inc., and bioMérieux, Inc. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-2881

Blood Bank Reagent Market: Segmentation

Blood bank reagent market is segmented by test type, reagents and geography:

By Test Type

  • ABO Typing
  • Antibody Screening
  • Cross Matching Test

By Reagents

  • Anti-Sera Reagents
  • Reagent Red Blood Cells
  • Anti-Human Globulin
  • Blood Bank Saline

Neurointerventional Devices Market to surge at 8% CAGR from 2020-2030, Analysis By Future Market Insights

A new report by Future Market Insights (FMI) expects global neurointerventional devices market to grow at 7.8% CAGR through 2030. According to the study, the market will reach USD 5 billion in revenues by the end of 2030.

Since the past several years, the burden of neurological disorders has increased multifold. According to the National Center for Biotechnology Information (NCBI), the frequency of cerebral aneurysm is nearly 3.2%, with the prevalence being higher amongst women than men above 50 years of age.

It is estimated that around 6.5 million people in the United States possess an unruptured brain aneurysm, while 30,000 suffer a brain aneurysm rupture every year. Based on these trends, it is unsurprising to observe the market being interspersed with the presence of several reputed manufacturers who constantly launch new products.

In addition, rising prevalence of ischemic stroke is also boosting the neurointerventional devices market. Being non-invasive in nature, these devices increase chances of survival during surgery, further fueling market growth. By 2030, a valuation of US$ 4.8 Bn is predicted for the market.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-871

Global Neurointerventional Devices Market- Key Takeaways

  • North America shall be the market hegemon, holding a 40.7% market share from 2020-2030
  • Embolic coils to capture the majority share, carotid stents to surge in popularity
  • High incidence of cerebral aneurysm to accelerate adoption of coiling procedures
  • Presence of experienced surgeons shall accelerate hospital-grade neurointerventional device adoption

COVID-19’s Impact on the Market

With respect to neurological disorders, several hospitals and clinics have reported complications in severely or critically ill patients with co-morbidities. COVID-19 has the potential to affect the central and peripheral nervous systems. The virus invades the brain either through the olfactory system or a hematogenous route. Once inside, the virus may cause hypoxic and metabolic abnormalities.

In this light, the neurointerventional devices market is poised to remain afloat in the near-term forecast period. Significant increases in mechanical thrombectomies were reported since April 2020, with majority of the patients seeking treatment for acute strokes from large vessel occlusions (LVOs).

A series of case studies on over 200 COVID-19 positive patients in Wuhan, China, 36.4% of patients exhibited neurologic symptoms such as acute cerebrovascular events, muscle injury and impaired consciousness. In this context, the market is poised to experience an adrenaline rush in the short-run.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-871

Competitive Intelligence

Some influential vendors within the landscape include: Stryker Corporation, Covidien Public Ltd., Penumbra Inc., Terumo Corporation, Johnson & Johnson Private Limited, Medtronic PLC, Boston Scientific Corporation and Abbott.

Players are emphasizing on expanding their businesses through partnerships, collaborations and mergers & acquisitions and participation in trade fairs. Many of them are also aligning with research institutes to augment their research capacities.

In August 2020, Stryker Corporation successfully launched its Surpass Evolve flow diverter after receiving FDA clearance in the U.S market. The device has already been in use in Europe since 2019.

In September 2020, Penumbra Inc. shall participate in the virtual Global Embolization Symposium & Technologies 2020 Conference. The company hopes to broaden its outreach and collaborate with other leading players to develop and launch new neurointerventional devices, thus expanding its existing product portfolio.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-871

More Insights into the Neurointerventional Devices Market

A recent market study published by FMI on the digital wound measurement devices market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. Our analysts have conducted thorough research on the historical as well as current growth parameters of the market to obtain growth prospects with maximum precision.

Ethylene Glycol Market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031

According to the latest research, the demand for Ethylene Glycol Market is anticipated to grow with a compelling growth rate of about 3.1% to 4.5 % in between the coming assessment period of 2021-2031.

It is mainly used as a raw material in the manufacture of polyester fibres and for antifreeze formulations.

What is Driving Demand for Ethylene Glycol

Major factors driving the market are the growing demand from the textile industry and automotive industry. The availability of enhanced ethylene glycol production technology, increased popularity of bio-based ethylene glycol, and rising demand from the textile industry are projected to fuel market expansion throughout the forecast period.

Rapid growth in the textile and PET resin products industries is expected to boost the consumption during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13820

The packaging industry has been driven by rapid growth and changing lifestyles of consumers, and the growing use of Polyethylene Terephthalate (PET) in a variety of consumer goods products, including as food containers and bottles, is expected to enhance demand for MEG which is likely to boost the market throughout the forecast period.

Growth of automotive sector to boost the market and increase demand of Ethylene Glycol

It is widely used as an antifreeze in automobile engines. Because it has a lower freezing point than water, it is used to keep an automobile radiator cool throughout the winter.

Globally, the number of vehicles on the road is increasing and is expected to grow at a CAGR of 4.5 percent.

Growing vehicle production and sales volumes are to responsible for the increase in vehicle on-road volumes. Coolants and antifreeze will be in high demand due to the increased number of vehicles on the road.

The demand for MEG will be fuelled by an increase in coolants and antifreeze usage.

Many end use industries depend on the use of ethylene glycol as a feedstock. It’s mostly used to make PET bottle resins, polyester fibre, and films. Fibre is the most common application of MEG.

Due to the usage of MEG in the production of PET and polyester fibres, it is widely used in the textile and apparel industries, as well as garment manufacturing, home furnishings, carpets, and rugs. Hence the market is expanding due to the high potential for polyester applications in the textile industry.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13820

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Halal Nutraceuticals & Vaccines Market Size Estimates and Forecasts by Region, Growth Rate and Trend Analysis by Types and Application 2021 to 2031

ESOMAR-certified consulting firm Future Market Insights’ report, projects a steady growth of global halal nutraceutical & vaccines market. The report has forecast the market to reach a valuation of US$ 116381.3 Mn over the forecast period of 2021 and 2031.

Growing demand for halal dietary supplements from Muslim dominant countries is accelerating the demand of halal nutraceutical & vaccines across the globe.

Key players are investing heavily in order to adhere to the regulations of halal products to cater the demand. Initiatives undertaken and increased funding for the promotion of halal dietary supplements across Malaysia, UAE, Singapore and China will bolster the growth.

Development of halal products for vegetarian customers with the increasing prevalence of lifestyle disorders such as diabetes, obesity and others are propelling the demand for halal dietary supplements.

As per the FMI’s analysis, due to the high demand from the GCC countries, Indonesia and Malaysia for dietary supplements & other products, the market witnessed steady growth at 6.50% CAGR during 2016-2020.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2703

However, high cost of production in compliance to the regulation of halal certification will impede the market growth. Less production and demand from the U.S, the U.K and other western countries might hamper the demand.

Key Takeaways from FMI’s Halal nutraceutical & vaccines Market Study

  • By distribution channel, hospital pharmacies segment will remain highly sought-after for halal nutraceutical & vaccine sales.
  • In terms of application type, general wellbeing will retain its dominance, while immune & digestive health will account for second largest application
  • Halal dietary supplements will dominate the halal nutraceutical & vaccines market in terms of product over the forecast period
  • Indonesia and Switzerland will emerge as the leading market across Asia Pacific excluding Japan backed by the high demand of halal dietary supplements
  • UAE will emerge as the most lucrative market registering fastest growth in terms of value over the forecast period
  • Malaysia is anticipated to lead the Asia’s Halal nutraceutical & vaccines market, exhibiting the growth at 18.3% CAGR

Competitive Landscape

Prominent halal nutraceutical & vaccines market players profiled by Future Market Insights include Chemical Company of Malaysia Berhad, Abbott Laboratories, Nestle, Amway, Herbalife International of America Inc., AJ Biologics SDN BHD, Agropur Inc., PT Kalbe Farma TBK, Kotra Pharma SDN BHD, and Noor Vitamins among others.

Abbott Laboratories and Herbalife International of America, Inc. are two leading companies dominating the global halal nutraceuticals & vaccines market.

While Abbott Laboratories is expected to focus on producing halal nutraceutical & vaccines for infants, women and specific therapeutic nutrition, Herbalife is emphasizing its business measures more towards consumer awareness through promotional campaigns.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2703

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

DNA Polymerase Market size, Insights, Prospects, Growth Trends, Key Trends, Opportunities and Forecast until 2031

A growing number of drug patent expirations and the interest in generic biologics has gained significantly from developments in the DNA polymerase market. Rising demand for improvements in healthcare diagnostics are expected to remain key influencer in market growth. According to Future Market Insights, a new study has forecast the DNA polymerase market to exhibit a CAGR of approximately 6.5% during the forecast period from 2021 to 2031.

Major manufacturers in the DNA polymerase market are increasingly focused on investing in research and development efforts to widen the scope of applications in the sector. In addition, strategic acquisitions and collaborations to share expertise, leveraging biopharmaceuticals and contract manufacturing companies will find ground in the industry.

In terms of end users, molecular diagnostics companies are likely to remain primary contributors to the market accounting for more than 30% of the global market share. Furthermore, academic and research institutes will display a relatively faster rate of growth, driven by investments into R&D for accuracy in diagnostics, genome research, DNA cloning, and potential applications in cancer research.

Increasing R&D activities is a key factor positively influencing the development and use of high-fidelity DNA polymerase. Increasing incidences of cancer, concerns over uncontrolled genetic mutations, increasing awareness on neurological disorders, and potential for treating chronic diseases create lucrative opportunities in the DNA polymerase market. Also, the growing importance being given to personalized medicine will provide impetus to market players through the coming decade.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-801

On the other hand, DNA polymerase market players are expected to face a number of challenges during the forecast period. For instance, shortage of adequately skilled professionals is a restraining factor affecting the market. Lack of information and awareness associated to DNA polymerase also affects sales prospects. Also, a shortage of funding by governments in the sector are restraining market growth. These factors are especially true in developing countries with restricted access to capital and infrastructure.

Key Takeaways from DNA Polymerase Market Study

  • The global DNA polymerase market is projected to grow at approximately 6.5% CAGR through the projection period.
  • Molecular diagnostic applications will account for major market, with impetus from the covid-19 pandemic.
  • The U.S. will hold the lead in North America accounting for more than 50% of the global valuation.
  • China will reflect high growth potential accounting for a CAGR of over 7.5%, owing to rising healthcare spending.
  • UK will reflect high demand in Europe supported by the rise of contract research and manufacturing organizations in biopharmaceuticals.

Who is Winning?

The global DNA polymerase market is set to widen its scope of expansion through the assessment period, driven by a higher rate of adoption in molecular diagnostics, bioprocessing, cancer research and development of generic biologics in the biopharmaceutical sector. A shortage of adequately skilled professionals and lack of awareness has restrained revenue in the industry.

Some of the more prominent players in the DNA polymerase market include but are not limited to Thermo Fisher Scientific Inc., Hoffmann-La Roche AG, Merck KGaA, Qiagen N.V., Agilent Technologies Inc., Takara Bio Inc., Genescript, Illumina Inc., New England Biolabs, Inc., Bioline, and Promega Corporation.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-801

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Stool Management Systems Market Analysis by Growth, segmentation, performance, Competitive Strategies and Forecast to 2031

According to Future Market Insights (FMI), the demand for stool management systems is expected to rise significantly, reaching a market value of USD$ 166.5 Mn by the end of 2021.

Stool management systems are designed for bed ridden patients with fecal incontinence, a condition commonly known as bowel incontinence. These systems are used to prevent infections and reduce nursing time requirements.

The stool management systems are advantageous for older adults and patients suffering from constipation and fecal incontinence. Furthermore, it is also helpful for bed-ridden patients who may have been subject to aliments such as strokes, paralysis, or spinal injury.

According to the World Bank, approximately 700 million people were aged 65 and above in the world in 2019. Consequently, the overall high incidence of geriatric populations is resulting in the expansion of the patient pool and the resultant increase in the demand for stool management systems globally.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-3568

Fecal incontinence issues are common around the world and it has a notable burden on the economy and healthcare systems of society. The condition has impacted the economic system including hospital charges and nursing charges. Stool management systems help in reducing the nursing time and other hospital expenses.

Key players are focusing on strengthening their mergers and acquisition portfolios, in addition to advancement in technologies and new product launches. Europe holds the highest share in the market due to a vast target demographic, the presence of major market players, and high healthcare expenditure in the region.

Key Takeaways from Stool Management Systems Market Study

  • Systems are key to revenue generation in the stool management systems market surpassing accessories. They are likely to account for 63% value share by the end of the forecast period.
  • Luer-lock syringes will lead, with a valuation of over US$ 16 Bn by the end of 2021 owing to security in drug administration processes.
  • The U.S. accounts for more than 92% share in the North America market, and will witness growth backed by presence of a well-established healthcare sector.
  • Germany and France are leading countries in Europe and will account for more than 18% and 16% of the Europe market respectively in 2021.
  • Australia is the largest and fastest growing market in Oceania, exhibiting 6.2% CAGR during the forecast period.

Who is Winning?

The global stool management systems market is set to expand due to the rising number of people suffering from stool related ailments. Leading organizations within the market are set to focus on research for healthcare systems to offer increasingly effective treatment options for superior patient outcomes.

Some of the leading players in the stool management systems market include B. Braun Melsungen AG, Becton Dickinson, ConvaTec, Inc., Hollister Incorporated, Prosyn International Ltd., Consure Medical and others.

Want More Insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels that provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global stool management systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the stool management systems market on basis of the product type in detail, cover every aspect of the market such as systems, accessories and major regions.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-3568

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Clinical Trials Market Size (Value & Volume), Future Trends, Opportunities and Sales Channels, Forecast 2029

The study offers a long-term forecast of the clinical trials landscape for the period between 2019 and 2029. The clinical trials landscape is projected to record a 4.5% CAGR through 2029.

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018. The healthcare sector is closing in on a new era of clinical trials, which are more engaged with patients, streamlined and connected. With development costs reaching record highs and patents approaching cliffs, companies are strengthening their R&D efforts to keep pace with change. Medical device and pharma giants are already eyeing better approaches for clinical trials, implementing a combination of their current systems and better technologies to ebb challenges in critical areas – orphan drugs and rare diseases.

According to the study, the clinical trials landscape is witnessing a paradigm shift toward patient centricity, in a bid to incorporate perspective of patients during the clinical trial design. Clinical trial sponsors have aligned their methods with the voice of patients, by launching communication channels during the study’s execution. Key enterprises are adopting unconventional approaches by implementing site-centric method, using operational support systems and technology for bringing studies to the trial-naïve physicians.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-384

Industry Sponsors Account for Majority Clinical Trial Spending

The most remarkable advances in medicine are realized from sponsorships of companies for clinical trials, in the anticipation of turning a profit. A notable percentage of clinical trials being conducted to support approval of vaccines, devices, or drugs, and track their safety, have been industry-sponsored in recent years.

The study estimates industry-sponsored clinical trials to account for ~60% of overall spending in 2019, and in the foreseeable future. Recent studies state that industry-sponsored trials yield positive results compared to academic-run trials, which also account for a significant share of clinical trial spending.

According to FMI, sponsors, such as academic institutes, research institutes and medical centers, are estimated to account for ~30% clinical trial spending in 2019. As the imperativeness of evidence-based therapies continue to be progressively emphasized, most of the randomized clinical trials are driven by the ability of developing profitable new therapies. Guidelines recommended by regulatory bodies for clinical trial enrichment, and risk-based monitoring are likely to lay the groundwork for more targeted approach toward cost-intensive clinical trials.

The study opines that North America and Europe will continue to lead the clinical trials landscape, collectively accounting for ~80% of global spending. These regions present a standardized and favorable environment for the clinical trials landscape, in light of their economic vigor that enables them to benefit from most of the technology disruptions prior to other nations. Pharmaceutical and medical device giants in these two regions are adopting AI for disrupting every stage of the clinical trial, which range from linking studies to eligible patients, to data collection and adherence.

According to the study, opportunities abound for conducting clinical trials in developing economies, such as in East Asia and South Asia, owing to the access to huge patient pool. Sponsors are likely to realize greater success in these regions as low government healthcare budgets represent cost-effective methods of providing patients with access to innovative therapies. Additionally, conducting clinical trials in these regions comes with other broader advantages, including pragmatic & efficient regulatory pathway, and tax incentives for conducting the trials.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-384

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Eye Tracking System Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2028

The US$ 472 million eye tracking system market is slated to take a whopping leap over the next decade, reaching the value equating US$ 5 Bn by the end of 2028. As depicted in a recently released intelligence outlook by Future Market Insights, the global market for eye tracking system will exhibit an exceptionally high growth rate – predominantly driven by brisk technological advances and an expanding application base of eye tracking system in assistive communication devices.

However, the market for eye tracking system will continue to position itself in the high-growth low-volume quadrant throughout the projection period.

FMI anticipates the global eye tracking system market expansion at a massive CAGR of 26.6% between 2018 and 2028. While the capability of eye tracking system to offer unique insights to help comprehend human behavior will remain the most prominent factor driving its demand worldwide, FMI also marks rapid technological advances in software solutions and hardware components to continue fueling the growth of eye tracking system market through 2028.

Although concerns regarding the safety, privacy, and security of eye tracking data continues to surround the methods used for data collection and use, strong efforts are being taken by some of the leading stakeholders in the eye tracking system market to assure data privacy and security.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-2010

Key Research Findings

  • Europe and North America, the current leaders in the global eye tracking system market, will continue to represent higher value shares in the total market value throughout 2018-2028.
  • The demand for eye tracking system is most likely to gain a significant boost in Asia Pacific by descending price points and an extending application base – especially in the academic research realm and multiple commercial areas.
  • Although remote eye tracking system currently dominates the global market, FMI expects the wearable eye tracking system to demonstrate relatively faster growth – accounting for a larger share of revenue in the eye tracking system market by 2028 end.
  • Based on application areas, assistive communication has been spearheading in terms of revenue generation. Moreover, smartphones, gaming, and AR/VR have been identified to represent the next big things creating attractive opportunities in the eye tracking system market over the forecast period.
  • The critical need for expert resources and services for appropriately using the volumes of relevant and actionable data cannot be overstated, especially in case of research in medical and academic areas, and consumer behavior.

Combined Use of Eye Tracking System with Biometric Data Facilitating Understanding of Human Decision Making

Though conventionally provided data by eye tracking system involves the position of gaze, fixations, and the areas of interest of the subject that is being tracked vis-à-vis the visual stimuli, industry experts have been repeatedly highlighting the dearth of sufficient insights on the underlying emotions, perceptions, and experiences behind the tracked gaze patterns and fixations. To overcome this longstanding functional challenge, a large number of companies operating in the global eye tracking market are providing eye tracking data in integration with other biometric measures. According to FMI, electroencephalography (EEG), facial expression analysis, and electro-dermal activity analysis are some of the biometric measures that hold the potential to create relevant synergies with the existing eye tracking data.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2010

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Green Banana Flour Market is set to reach US$ 435.7 Mn by the end of 2021, New Study

Alternative flours are gaining traction especially since they are known to offset disadvantages of traditional whole wheat or wheat flour. According to a new study by Future Market Insights (FMI), the green banana flour market is set to reach US$ 435.7 Mn by the end of 2021. The rising demand for improved nutritional value in food along with new flavors, textures and aromas, among consumers are enabling sales in the market.

Green banana flour is trending as a gluten-free ingredient for the food industry, which in turn is creating opportunities for key players to capitalize on. Changing buyers values have led to seek more nutrition from natural and high-quality food sources with clean labels. With consumers seeking healthier options, it is seen that these products have appeal across a broad spectrum of potential buyers.

Driven by consumers’ piqued interest, green banana flour is now being made available in a particular flavor or a combination of other fruit flavors. According to FMI, the demand for conventional green banana flour is remarkably high and it is expected to account for over 95% sales in 2021.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13028

Key Takeaways from the Green Banana Flour Market Study

  • Green banana flour market is expected to register 4.6% Y-o-Y growth in 2021
  • The U.S. will emerge as a highly attractive market, accounting for over 85% of sales in North America in 2021
  • Exhibiting above 6% Y-o-Y growth in 2021, the U.K. will emerge as an attractive market for green banana flour within Europe
  • The demand from Germany and France too is forecast to rise at an impressive pace
  • Within East Asia, China will exhibit strong growth, followed by Japan and South Korea

“The food industry is actively developing palatable products, allowing people with allergies to gluten and wheat enjoy breads, baked goods, pasta, and other food items made using processed flour. This has been one of the crucial drivers of green banana market. Green banana flour has a very mild raw banana taste; it also has a lighter wheat flour-like texture and needs around 25 % low volume, making it a strong wheat flour substitute, which will continue aiding sales through the forecast period,” said a lead analyst at FMI.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-13028

Quality Concerns Pertaining to Food Enabling Green Banana Flour Sales

Rising concerns regarding quality of food products, along with growing awareness about health & wellbeing, are pushing consumers to increasingly opt for healthy and organic products Green banana powder is being sold in its retail format for household purposes in large quantities. Growing purchasing power and increased opportunities for women in the workforce have resulted in less time for home cooking, and higher demand for processed or prepared foods. As a result, there is a rise in consumer expenditure on grocery retail and food.

Not only is it a must for those with gluten allergies to use substitute flours, but it’s also a perfect choice for many recipes to add nutrients. Green banana flour is lower in calories than all-purpose flour at only 100 calories per 1⁄4 cup, which essentially helps minimize the total calorie count without losing flavour or texture.

Who is winning?

Rising inclination towards vegetable and fruit flours across various regions is fuelling the demand for green banana flour. Manufacturers across the globe are are investing heavily to update their inventories with green banana flour products to cater to the growing demand.

For instance, Zuvii specializes in the production and marketing of gluten-free food ingredients for both retail and commercial sectors. The company offers products such as gluten-free banana flour, pancake and waffle mix, brownie mix, chocolate cake mix, vanilla cake mix, and bundles. The green banana flour produced by the company is claimed to be starch free, and good for the gut due to its probiotic nature.

Some of the key players in green banana flour market are are International Agriculture Group, Made’s Green Banana Flour Co., Kanegrade Ltd., Natural Evolution Limited, Slingan Pty Ltd., NOW Health Group, Inc, NuNatural Inc, Zuvii, Pereg Gourmet Natural Foods, M-Pak, Banatone Food Industries, Stawi Foods and Fruits Limited, Vinayak Ingredients (INDIA) Pvt. Ltd., Hearthy Foods, Saipro Biotech Private Limited, Paradise Fruits, Royal Nut Company, Absolute Organic, KADAC Pty Ltd.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-13028

Get Valuable Insights into green banana flour market 

Future Market Insights, in its new offering, provides an unbiased analysis of the green banana flour market presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the green banana flour market based on product type (Organic Green Banana Flour and Conventional Green Banana Flour), by process (Freeze Dried Process, Spray Dried Process, Sun Dried Process and Others), by Sales channel (Direct Sales and Indirect Sales), and by application (Household, Food Industry, Beverages, Pet Food & Feed Industry).